Litigation in Generic Markets: How Patent Disputes Delay Affordable Medicines
Patent litigation in generic drug markets delays affordable medicines through strategic lawsuits, improper patent listings, and settlements. Learn how the Hatch-Waxman Act is being exploited-and what’s being done to fix it.
Read More